Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-08

Clinical Trial Update: Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia [Phase 4]

View source ↗

Summary

Phase 4 trial update on metformin for recurrent miscarriage in a hyperinsulinemic patient; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Abortion, Habitual | Phase 4 | Status: WITHDRAWN